Hwang et al.132transfected NFAT1 siRNA into activated CD4+ T cells, and IL-31 expression levels were considerably decreased, suggesting the potential of NFAT1 siRNA to treat IL-31-mediated AD symptoms. This evidence concerns the gene NFATC2 and Alzheimer disease.